Mitigation of Pre-existing Antibodies to a Biotherapeutic in Non-clinical Species When Establishing Anti-drug Antibody Assay Cutpoint
Crossref DOI link: https://doi.org/10.1208/s12248-016-0011-2
Published Online: 2016-11-21
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kumar, Seema C
DelCarpini, Jason A
Qu, Qiang
Kane, Martin
Gorovits, Boris
License valid from 2016-11-21